Indoco Remedies Limited

BSE:532612 Stock Report

Market Cap: ₹22.4b

Indoco Remedies Management

Management criteria checks 2/4

Indoco Remedies' CEO is Sundeep Bambolkar, appointed in Feb 2012, has a tenure of 13.83 years. total yearly compensation is ₹80.57M, comprised of 63.6% salary and 36.4% bonuses, including company stock and options. directly owns 0.51% of the company’s shares, worth ₹113.76M. The average tenure of the management team and the board of directors is 9 years and 18.7 years respectively.

Key information

Sundeep Bambolkar

Chief executive officer

₹80.6m

Total compensation

CEO salary percentage63.65%
CEO tenure13.8yrs
CEO ownership0.5%
Management average tenure9yrs
Board average tenure18.7yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Sundeep Bambolkar's remuneration changed compared to Indoco Remedies's earnings?
DateTotal CompensationSalaryCompany Earnings
Sep 30 2025n/an/a

-₹1b

Jun 30 2025n/an/a

-₹1b

Mar 31 2025₹81m₹51m

-₹737m

Dec 31 2024n/an/a

-₹107m

Sep 30 2024n/an/a

₹321m

Jun 30 2024n/an/a

₹767m

Mar 31 2024₹76m₹47m

₹985m

Dec 31 2023n/an/a

₹1b

Sep 30 2023n/an/a

₹1b

Jun 30 2023n/an/a

₹1b

Mar 31 2023₹65m₹40m

₹1b

Dec 31 2022n/an/a

₹2b

Sep 30 2022n/an/a

₹2b

Jun 30 2022n/an/a

₹2b

Mar 31 2022₹46m₹30m

₹2b

Dec 31 2021n/an/a

₹1b

Sep 30 2021n/an/a

₹1b

Jun 30 2021n/an/a

₹1b

Mar 31 2021₹28m₹20m

₹930m

Dec 31 2020n/an/a

₹734m

Sep 30 2020n/an/a

₹571m

Jun 30 2020n/an/a

₹393m

Mar 31 2020₹18m₹15m

₹241m

Dec 31 2019n/an/a

₹302m

Sep 30 2019n/an/a

₹264m

Jun 30 2019n/an/a

₹111m

Mar 31 2019₹15m₹12m

-₹29m

Compensation vs Market: Sundeep's total compensation ($USD888.15K) is above average for companies of similar size in the Indian market ($USD195.71K).

Compensation vs Earnings: Sundeep's compensation has increased whilst the company is unprofitable.

CEO

Sundeep Bambolkar (65 yo)

13.8yrs
Tenure
₹80,565,000
Compensation

Mr. Sundeep Vasant Bambolkar has been a Joint Managing Director at Indoco Remedies Limited since February 15, 2012. Mr. Bambolkar served as Chief Financial Officer at Indoco Remedies Limited from March 23,...

Leadership Team

NamePositionTenureCompensationOwnership
Suresh Kare
Non-Executive Chairman & Whole time Director62.4yrs₹200.00k1.7%
₹ 379.9m
Sundeep Bambolkar
Joint MD & Executive Director13.8yrs₹80.57m0.51%
₹ 113.8m
Aditi Panandikar
MD & Executive Director13.8yrs₹91.07m11.37%
₹ 2.5b
Pramod Ghorpade
Chief Financial Officer4.1yrs₹19.01mno data
Ramanathan Hariharan
Head of Legal3yrs₹6.46mno data
Dileep Mahajan
Vice President of Operationsno datano datano data
Kavita Inamdar
Chief Technical Officerno data₹7.57mno data
Ajay Karajagi
President of Sales & Marketingno datano datano data
Rajesh Usgaonker
Chief Marketing Officerno datano datano data
Rajan Saawant
Vice President of Corporate HRno datano datano data
Prashant Pathak
Head Formulation of Planning & Operationsno datano datano data
Abhilash Soral
Executive Vice President of International Business for Regulated Marketsno datano datano data
9.0yrs
Average Tenure
61.5yo
Average Age

Experienced Management: 532612's management team is seasoned and experienced (9 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Suresh Kare
Non-Executive Chairman & Whole time Director62.4yrs₹200.00k1.7%
₹ 379.9m
Sundeep Bambolkar
Joint MD & Executive Director21.8yrs₹80.57m0.51%
₹ 113.8m
Aditi Panandikar
MD & Executive Director21.8yrs₹91.07m11.37%
₹ 2.5b
Divakar Gavaskar
Independent Non-Executive Director20.7yrs₹580.00kno data
Rajiv Kakodkar
Independent Non-Executive Director18.7yrs₹660.00kno data
Anand Nadkarni
Non-Executive Director11.6yrs₹260.00kno data
Vasudha Kamat
Non-Executive & Independent Director5.8yrs₹480.00kno data
Satish Shenoy
Independent Non-Executive Director1.7yrs₹460.00kno data
Ajay Mulgaokar
Independent Non-Executive Director1.7yrs₹520.00kno data
18.7yrs
Average Tenure
69yo
Average Age

Experienced Board: 532612's board of directors are seasoned and experienced ( 18.7 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/12/15 16:14
End of Day Share Price 2025/12/15 00:00
Earnings2025/09/30
Annual Earnings2025/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Indoco Remedies Limited is covered by 14 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Sriraam RathiAnand Rathi Shares and Stock Brokers Limited
Srivathsan RamachandranAvendus Spark
Rohit BhatBatlivala & Karani Securities India Pvt. Ltd.